Source: https://events.qwikcast.tv/public/QwikCast/QwikCastEvent?eventKey=6fa33093-453a-4d71-a098-f35286ce6393
Timestamp: 2019-05-22 15:18:05
Document Index: 574289583

Matched Legal Cases: ['art 2', 'art 2', 'art 2', 'art 2', 'art 2', 'art 2']

304: The Revised Substance Use Disorder Privacy Regulations of 42 C.F.R. Part 2
Richard Chapman, Chief Privacy Officer, University of Kentucky HealthCare
Litany Webster, Compliance Manager, University of Kentucky HealthCare
Glena Jarboe, Program Manager, University of Kentucky HealthCare
In 2017, for the first time in 30 years and in the midst of the ongoing opioid epidemic in the United States, federal regulators revised 42 CFR Part 2, which governs the confidentiality of a patient’s substance use disorder records and information
These substantive revisions represented SAMHSA’s effort to modernize the Part 2 regulations in light of the significant technological and regulatory changes in the healthcare system since Part 2’s last revision in 1987
This session will provide an overview of Part 2, discuss some of the more significant revisions from the final rule, including the revised patient consent requirements, and explore some of the practical compliance challenges faced by Part 2 providers